feno - nmthoracic.org · leslie kumpf rrt, cpft, ae-c. f e n o. not nitrous oxide. history of...
TRANSCRIPT
-
FeNO
B Y L E S L I E K U M P F, R RT, C P F T, A E - C
-
I’M A LITTLE BIT OF A GEEK
• Graduated from Henry Ford
with a degree in Respiratory
Therapy in 2006
• Currently working on my
BSRT
• Help start the RRT lead
asthma program at UNMH
• Currently working in
Interventional Pulmonary at
UNMH
LESLIE KUMPF RRT, CPFT, AE-C
-
F e N O
-
NOT NITROUS OXIDE
-
History of Nitric Oxide
-
JOSEPH PRIESTLY 1703-1804
• Nitric Oxide (1772)
• Nitrogen Dioxide
• Nitrous Oxide
• Hydrogen Chloride
• Ammonia
• Sulfur Dioxide
• Silicon Tetrafluoride
• Nitrogen
• Oxygen (Co-discovered with Carl Wilhelm Scheele)
• Carbon Monoxide
-
1977
Ferid Murad and his group published an
article titled,
“Nitric oxide activates guanylate cyclase
and increases guanosine 3′:5′-cyclic
monophosphate levels in various tissue
preparations”
Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proceedings of the National Academy of Sciences of the United States of America. 1977;74(8):3203-3207.
-
1980
Robert Furchgott and partner Zawadzki
published,
“The obligatory role of endothelial cells in
the relaxation of arterial smooth muscle
by acetylcholine.”
Nature. 1980 Nov 27;288(5789):373-6.
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.
Furchgott RF, Zawadzki JV.
-
1987
Luis J. Ignarro publishes,
“The Identification of Nitric Oxide as
Endothelium-derived Relaxing Factor”
Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proceedings of the National Academy of Sciences of the United States of America. 1987;84(24):9265-9269.
-
1991Pepke-Zaba et al.
publishes,
“Inhaled nitric
oxide as a cause of
selective pulmonary
vasodilator in
pulmonary
hypertension.”
Pepke-Zaba J, Hibenbottam TW, Dinh-Xaun AT, Stone D, and Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilator in pulmonary
hypertension. Lancet 338: 1173-1174, 1991
-
1992• Nitric Oxide is
name “Molecule of
the Year” by
Science Magazine
The molecule of the yearBY DE KOSHLAND JR
SCIENCE18 DEC 1992 : 1861
-
1993-1994Gustafsson et al.
Lundberg et al.
Stamler et al.
Barnes et al.
Elevated Exhaled Nitric Oxide in Allergen-Provoked Asthma Is Associated with
Airway Epithelial iNOS. Abraham B. Roos , Michiko Mori, Reidar Grönneberg,
Christina Österlund, Hans-Erik Claesson, Jan Wahlström, Johan Grunewald,
Anders Eklund, Jonas S. Erjefält, Jon O. Lundberg, Magnus Nord
Published: February 28, 2014
-
1 9 9 8
N O B E L P R I Z E
-
F R O M T H E PA S T TO T H E P R E S E N T
-
T H E B O D Y ’ S R E G U L AT I O N
O F N I T R I C OXI D E
-
CONSTITUTIVE NEURONALnNOS
• Calcium dependent
• Localized in airway
nerves
• Present in airway
smooth muscle
• Density decreases from
the trachea to the small
bronchi
• Present around
submucosal glands
Fabio LM, Ricciardolo PJ, Sterk BG, Gert F. Nitric Oxide in Health and Disease
of the Respiratory System. Physiol Rev 84: 731-765, 2004
-
INDUCIBLE
iNOS
• Calcium –independent
• Localized to
macrophages
• Can be expressed in
alveolar type II cells, lung
fibroblasts, airway
respiratory epithelial
cells, mast cells,
endothelial cells,
neutrophils and
chondrocytesFabio LM, Ricciardolo PJ, Sterk BG, Gert F. Nitric Oxide in Health and Disease of the Respiratory System. Physiol Rev 84: 731-765, 2004
-
CONSTITUTIVE ENDOTHELIALeNOS
• Calcium dependent
• Expressed in bronchial
epithelium and type II
alveolar epithelial cells
• Also localized in the
nasal mucosa and the
basal membrane of
ciliary microtubules
Fabio LM, Ricciardolo PJ, Sterk BG, Gert F. Nitric Oxide in Health and Disease of the
Respiratory System. Physiol Rev 84: 731-765, 2004
-
F e N O
& AIRWAY INFLAMMATION
-
BRONCHIAL ALVEOLAR LAVAGE
Increased exhaled nitric oxide
Increase in eosinophils
Warke T, Fitch P, Brown V, et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax. 2002;57(5):383-387. doi:10.1136/thorax.57.5.383.
-
LUNG BIOPSIES
Relationship between Exhaled Nitric Oxide and Mucosal Eosinophilic Inflammation in Children with Difficult Asthma, after Treatment with Oral Prednisolone. DONALD N. R. PAYNE , IAN M. ADCOCK , NICOLA M. WILSON , TIM OATES , MICHAEL SCALLAN , and
ANDREW BUSH. https://doi.org/10.1164/ajrccm.164.8.2101145 PubMed: 11704581
Received: January 30, 2001 Accepted: June 11, 2001
-
INDUCEDSPUTUM
Eosinophil count > 3%
FeNO > 8.3ppb
The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
Berry MA1, Shaw DE, Green RH, Brightling CE, Wardlaw AJ, Pavord ID. Clin Exp Allergy. 2005 Sep;35(9):1175-9.
-
F e N O
FACTORS AFFECTING VALUES
-
Factors Affecting FeNO Values
Age and/or sex
Spirometry maneuvers
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric
Oxide and Nasal Nitric Oxide. Am J Respir Crit Care Med Vol 171. 9123-930, 2005
-
Factors Affecting FeNO Values
Airway caliber
Food and beverages
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric
Oxide and Nasal Nitric Oxide. Am J Respir Crit Care Med Vol 171. 9123-930, 2005
-
Factors Affecting FeNO Values
Circadian rhythm
Smoking
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric
Oxide and Nasal Nitric Oxide. Am J Respir Crit Care Med Vol 171. 9123-930, 2005
-
Factors Affecting FeNO Values
Infection
Medications
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric
Oxide and Nasal Nitric Oxide. Am J Respir Crit Care Med Vol 171. 9123-930, 2005
-
AT S
RECOMMENDATIONS
Dweik RA, Boggs PB, Erzurum SC, et al. An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications. American Journal of Respiratory and Critical Care Medicine. 2011;184(5):602-615. doi:10.1164/rccm.9120-11ST.
-
ATS RECOMMENDATIONS
• “We recommend the use of FeNO in the diagnosis of eosinophilic
airway inflammation.”
• “We recommend the use of FeNO in determining the likelihood of
steroid responsiveness in individuals with chronic respiratory
symptoms possible due to airway inflammation.”
Dweik RA, Boggs PB, Erzurum SC, et al. An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO)
for Clinical Applications. American Journal of Respiratory and Critical Care Medicine. 2011;184(5):602-615. doi:10.1164/rccm.9120-11ST.
-
ATS RECOMMENDATIONS
• “We suggest that FeNO may be used to support the diagnosis of
asthma in situations in which objective evidence is needed.”
• “We suggest the use of cut points rather than reference values
when interpreting FeNO levels.”
Dweik RA, Boggs PB, Erzurum SC, et al. An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO)
for Clinical Applications. American Journal of Respiratory and Critical Care Medicine. 2011;184(5):602-615. doi:10.1164/rccm.9120-11ST.
-
ATS RECOMMENDATIONS
• “We recommend accounting for age as a factor affecting FeNO in
children younger than 12 years of age.”
• “We recommend that low FeNO (< 25ppb) be used to indicate
that eosinophilic inflammation and responsiveness to
corticosteroids are less likely.”
Dweik RA, Boggs PB, Erzurum SC, et al. An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO)
for Clinical Applications. American Journal of Respiratory and Critical Care Medicine. 2011;184(5):602-615. doi:10.1164/rccm.9120-11ST.
-
ATS RECOMMENDATIONS
• “We recommend that FeNO (> 50ppb) be used to indicate that
eosinophilic inflammation and in symptomatic patients,
responsiveness to corticosteroids are likely.”
• “We recommend that FeNO values between 25ppb and 50ppb
should be interpreted cautiously with reference to the clinical
context.”
Dweik RA, Boggs PB, Erzurum SC, et al. An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO)
for Clinical Applications. American Journal of Respiratory and Critical Care Medicine. 2011;184(5):602-615. doi:10.1164/rccm.9120-11ST.
-
ATS RECOMMENDATIONS
• “We recommend accounting for persistent and/or high allergen
exposure as a factor associated with higher levels of FeNO.”
• “We recommend the use of FeNO in monitoring airway
inflammation in patients with asthma.”
Dweik RA, Boggs PB, Erzurum SC, et al. An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO)
for Clinical Applications. American Journal of Respiratory and Critical Care Medicine. 2011;184(5):602-615. doi:10.1164/rccm.9120-11ST.
-
F R O M T H E P R E S E N T TO T H E F U T U R E
-
TA K E AWAY S
-
T H A N K Y O UL E S L I E K U M P F R R T , C P F T , A E - C